-
EP4368641
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4368641
| EP4368641 - KAPPA MYELOMA ANTIGEN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF [Right-click to bookmark this link] | Status | The application has been published Status updated on 12.04.2024 Database last updated on 02.11.2024 | Most recent event Tooltip | 12.07.2024 | Publication of search report | published on 14.08.2024 [2024/33] | 12.07.2024 | Change - classification | published on 14.08.2024 [2024/33] | 12.07.2024 | Change - classification | published on 14.08.2024 [2024/33] | Applicant(s) | For all designated states HaemaLogiX Ltd. Suite 204 80 William Street Woolloomooloo NSW 2011 / AU | [2024/20] | Inventor(s) | 01 /
MICKLETHWAITE, Kenneth Westmead, 2145 / AU | 02 /
DUNN, Rosanne Eveleigh, 2015 / AU | 03 /
GOTTLIEB, David Westmead, 2145 / AU | 04 /
LOGAN, Grant Westmead, 2145 / AU | [2024/20] | Representative(s) | Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | [2024/20] | Application number, filing date | 24151551.9 | 25.04.2016 | [2024/20] | Priority number, date | US201562151968P | 23.04.2015 Original published format: US 201562151968 P | US201562158407P | 07.05.2015 Original published format: US 201562158407 P | [2024/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4368641 | Date: | 15.05.2024 | Language: | EN | [2024/20] | Type: | A3 Search report | No.: | EP4368641 | Date: | 14.08.2024 | Language: | EN | [2024/33] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.07.2024 | Classification | IPC: | C07K16/28, C07K14/705, C07K14/725, C07K16/30, A61K38/20, A61K39/395, A61K35/17, C07K14/54, C12N5/0783, A61K39/00, A61P35/00, A61P43/00, C07K16/00 | [2024/33] | CPC: |
A61K38/204 (EP,IL,RU,US);
C07K16/30 (IL,KR,RU,US);
C12N5/0636 (EP,IL,KR,RU,US);
C07K14/7051 (EP,IL,KR,RU,US);
A61K39/395 (IL,RU,US);
A61K2239/31 (EP,IL,KR,RU,US);
A61K2239/38 (EP,IL,KR,RU,US);
A61K2239/46 (EP,IL,KR,RU,US);
A61K39/4611 (EP,IL,KR,RU,US);
A61K39/4631 (EP,IL,KR,RU,US);
A61K39/4644 (EP,IL,KR,RU,US);
A61P35/00 (EP);
A61P43/00 (EP);
C07K14/5412 (EP,RU,US);
C07K14/5434 (EP,RU,US);
C07K14/70521 (EP,IL,KR,RU,US);
C07K16/2887 (EP,IL,KR,RU,US);
C07K16/2896 (EP,IL,KR,RU,US);
A61K2039/505 (EP,IL,KR,US);
C07K2317/526 (EP);
C07K2317/53 (EP,IL,KR,US);
C07K2317/56 (EP,IL,KR,US);
C07K2319/03 (EP);
C07K2319/035 (EP,IL,KR,US);
C12N2510/00 (EP,IL,US)
(-)
|
| Former IPC [2024/20] | C07K16/30 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/20] | Title | German: | CHIMÄRE ANTIGENREZEPTOREN DES KAPPA-MYELOM-ANTIGENS UND VERWENDUNGEN DAVON | [2024/20] | English: | KAPPA MYELOMA ANTIGEN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | [2024/20] | French: | RÉCEPTEURS ANTIGÉNIQUES CHIMÉRIQUES D'ANTIGÈNE DE MYÉLOME KAPPA ET LEURS UTILISATIONS | [2024/20] | Parent application(s) Tooltip | EP16784085.9 / EP3286223 | Fees paid | Renewal fee | 12.01.2024 | Renewal fee patent year 03 | 12.01.2024 | Renewal fee patent year 04 | 12.01.2024 | Renewal fee patent year 05 | 12.01.2024 | Renewal fee patent year 06 | 12.01.2024 | Renewal fee patent year 07 | 12.01.2024 | Renewal fee patent year 08 | 13.03.2024 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO03004056 (PACMAB PTY LTD [AU], et al); | [A]WO2010115238 (IMMUNE SYSTEM THERAPEUTICS LTD [AU], et al); | [XP]WO2015164739 (BLUEBIRD BIO INC [US]); | by applicant | US7344715 | US7556803 |